Concord Healthcare (HKG:2453) agreed to place 48.72 million new H shares at HK$5.54 each to no fewer than six institutional or professional investors to raise net proceeds of about HK$258.8 million, according to a Tuesday filing.
The placing price represents a 16.9% discount to the company's last closing price on July 21 and a 19.9% discount to the five-day average closing price.
The new shares represent about 18.38% of Concord's issued H shares and 6.63% of its total issued share capital before the placement.
Proceeds will be used to fund the construction of a Shanghai cancer hospital, support medical AI operations, repay financial institution loans, and supplement general working capital, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。